Cas 1257446-11-9,(R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid

1257446-11-9

Post Buying Request

Basic information

Product Name: (R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid
Synonyms: (R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid
CAS NO:1257446-11-9
Molecular Formula:
Molecular Weight: 404.422
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid(CAS DataBase Reference)
NIST Chemistry Reference: (R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid(1257446-11-9)
EPA Substance Registry System: (R)-2-(1-(biphenyl-4-yl)-3-carboxypropan-2-ylcarbamoyl)isonicotinic acid(1257446-11-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1257446-11-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1257446-11-9 Suppliers

Recommended suppliers

1257446-11-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1257446-11-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,4,4 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1257446-11:
(9*1)+(8*2)+(7*5)+(6*7)+(5*4)+(4*4)+(3*6)+(2*1)+(1*1)=159
159 % 10 = 9
So 1257446-11-9 is a valid CAS Registry Number.

1257446-11-9Upstream product

1257446-11-9Downstream Products

1257446-11-9Relevant academic research and scientific papers

SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS

-

Page/Page column 193-194, (2010/12/26)

The present invention provides a compound of formula I' or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, B1, X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1257446-11-9